Innate Pharma (IPHYF) Assets Average (2018 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Innate Pharma's Assets Average history spans 4 years, with the latest figure at $700.0 million for Q4 2025.

• For Q4 2025, Assets Average fell 25.57% year-over-year to $700.0 million; the TTM value through Dec 2025 reached $700.0 million, down 25.57%, while the annual FY2025 figure was $96.6 million, 37.41% down from the prior year.
• Assets Average reached $700.0 million in Q4 2025 per IPHYF's latest filing, down from $940.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $940.4 million in Q4 2024 to a low of $700.0 million in Q4 2025.

Peer Comparison